Risk of Infection Associated With Administration of Intravenous Iron

Key Points Question In patients who require treatment with intravenous iron, what is the evidence that this intervention increases the risk of developing a new infection? Findings In this systematic review and meta-analysis of 154 randomized clinical trials that included 32 920 participants, intravenous iron was associated with an increased risk of infection. Meaning The results of this study suggest that, despite broad advocacy in clinical guidelines, intravenous iron may increase the risk of infection, which must be balanced with the potential benefits of treating anemia and reducing blood transfusion requirements.

[1]  M. Tanner,et al.  Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial. , 2020, The Lancet. Global health.

[2]  P. Ponikowski,et al.  Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial , 2020, The Lancet.

[3]  Karolina Kaluza,et al.  Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications , 2020, Current medical research and opinion.

[4]  L. Miles The end of the beginning: pre‐operative intravenous iron and the PREVENTT trial , 2020, Anaesthesia.

[5]  J. Browne,et al.  Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial , 2020, The Lancet.

[6]  B. Lämmle,et al.  The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial , 2020, Scientific Reports.

[7]  Rafael Bielza,et al.  Effect of intravenous iron on functional outcomes in hip fracture: a randomised controlled trial. , 2020, Age and ageing.

[8]  D. Sessler,et al.  Prospective observational study of postoperative infection and outcomes after noncardiac surgery: analysis of prospective data from the VISION cohort. , 2020, British journal of anaesthesia.

[9]  S. Pearson,et al.  Rapid increase in intravenous iron therapy for women of reproductive age in Australia , 2020, The Medical journal of Australia.

[10]  H. de Boer,et al.  A randomized controlled trial comparing oral and intravenous iron supplementation after Roux-en-Y gastric bypass surgery. , 2020, Clinical nutrition.

[11]  W. Winkelmayer,et al.  Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk , 2020, Kidney medicine.

[12]  T. Pieber,et al.  High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial. , 2020, Clinical nutrition.

[13]  S. Zodpey,et al.  Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial. , 2019, The Lancet. Global health.

[14]  Xin Yuan,et al.  Intravenous Iron Versus Placebo in the Management of Postoperative Functional Iron Deficiency Anemia in Patients Undergoing Cardiac Valvular Surgery: A Prospective, Single-Blinded, Randomized Controlled Trial. , 2019, Journal of cardiothoracic and vascular anesthesia.

[15]  Tae-Yop Kim,et al.  The Effect of Intraoperative Ferric Carboxymaltose in Joint Arthroplasty Patients: A Randomized Trial , 2019, Journal of clinical medicine.

[16]  Luis Ferrer-Barceló,et al.  Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding , 2019, Alimentary pharmacology & therapeutics.

[17]  B. Seifert,et al.  Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial , 2019, The Lancet.

[18]  S. Brunskill,et al.  Risk of infection associated with intravenous iron preparations: protocol for updating a systematic review , 2019, BMJ Open.

[19]  O. Sahota,et al.  The effect of intravenous iron on erythropoiesis in older people with hip fracture. , 2019, Age and ageing.

[20]  G. Kemp,et al.  Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency. , 2019, Circulation.

[21]  Christopher L. Wu,et al.  Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: infection and sepsis , 2019, British journal of anaesthesia.

[22]  E. Wood,et al.  Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference , 2019, JAMA.

[23]  E. Litton,et al.  Iron Metabolism: An Emerging Therapeutic Target in Critical Illness , 2019, Critical Care.

[24]  A. Darwish,et al.  RETRACTED ARTICLE: Total dose iron dextran infusion versus oral iron for treating iron deficiency anemia in pregnant women: a randomized controlled trial , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[25]  J. McMurray,et al.  Intravenous Iron in Patients Undergoing Maintenance Hemodialysis , 2019, The New England journal of medicine.

[26]  R. Porcher,et al.  Iron deficiency and infection: another pathway to explore in critically ill patients? , 2018, Intensive Care Medicine.

[27]  J. Allen,et al.  A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy. , 2018, Seminars in hematology.

[28]  C. Bokemeyer,et al.  Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines† , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  X. Capdevila,et al.  Preoperative Epoetin-&agr; with Intravenous or Oral Iron for Major Orthopedic Surgery: A Randomized Controlled Trial , 2018, Anesthesiology.

[30]  S. Madhusudan,et al.  Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma , 2018, Nutrition and cancer.

[31]  Hiroaki Ito,et al.  Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study , 2018, International Journal of Hematology.

[32]  A. Nevill,et al.  Intravenous iron does not effectively correct preoperative anaemia in cardiac surgery: a pilot randomized controlled trial. , 2018, Interactive cardiovascular and thoracic surgery.

[33]  A. Prentice,et al.  Reducing anaemia in low income countries: control of infection is essential , 2018, British Medical Journal.

[34]  H. Kehlet,et al.  An international consensus statement on the management of postoperative anaemia after major surgical procedures , 2018, Anaesthesia.

[35]  Élvio Bueno Garcia,et al.  Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil. , 2018, The Lancet. Haematology.

[36]  C. Boomershine,et al.  A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose in Iron-Deficient Patients with Fibromyalgia , 2018, Rheumatology and Therapy.

[37]  K. Prabhash,et al.  Phase III randomized trial comparing intravenous to oral iron in patients with cancer‐related iron deficiency anemia not on erythropoiesis stimulating agents , 2018, Asia-Pacific journal of clinical oncology.

[38]  H. Kim,et al.  Postoperative Intravenous Ferric Carboxymaltose Reduces Transfusion Amounts after Orthopedic Hip Surgery , 2018, Clinics in orthopedic surgery.

[39]  Ruili Li,et al.  Single‐dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo‐controlled study (PRACTICE‐ASIA‐HF) , 2018, ESC heart failure.

[40]  P. Meybohm,et al.  Post-Operative Iron Carboxymaltose May Have an Effect on Haemoglobin Levels in Cardiothoracic Surgical Patients on the ICU - an Observational Pilot Study about Anaemia Treatment with Intravenous Iron , 2018, Transfusion Medicine and Hemotherapy.

[41]  Y. Cho,et al.  Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome. , 2017, Sleep medicine.

[42]  P. Ponikowski,et al.  Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency , 2017, Circulation.

[43]  S. Spitalnik,et al.  Iron: a double‐edged sword , 2017, Transfusion.

[44]  C. Natanson,et al.  Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia , 2017, Transfusion.

[45]  K. Itani,et al.  Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017 , 2017, JAMA surgery.

[46]  W. Oertel,et al.  Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial , 2017, Movement disorders : official journal of the Movement Disorder Society.

[47]  N. Milman,et al.  Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP) , 2017, Journal of perinatal medicine.

[48]  Young-Woo Kim,et al.  Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial , 2017, JAMA.

[49]  P. Jaju,et al.  Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial , 2017, BMC Pregnancy and Childbirth.

[50]  A. Chatwani,et al.  Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia , 2017, Anemia.

[51]  N. I. Khouly Comparison of intravenous ferrous sucrose and oral ferrous sulphate in treatment of postpartum iron deficiency anemia , 2017 .

[52]  J. Langhoff‐Roos,et al.  Single‐dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial , 2017, Vox sanguinis.

[53]  Q. Jia,et al.  Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[54]  M. Brookes,et al.  Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer , 2017, The British journal of surgery.

[55]  H. Kehlet,et al.  International consensus statement on the peri‐operative management of anaemia and iron deficiency , 2017, Anaesthesia.

[56]  T. Deloughery,et al.  Single-dose intravenous iron for iron deficiency: a new paradigm. , 2016, Hematology. American Society of Hematology. Education Program.

[57]  Suchitra Thunga,et al.  IV Ferric Carboxymaltose Vs Oral Iron in the Treatment of Post-partum Iron Deficiency Anaemia. , 2016, Journal of clinical and diagnostic research : JCDR.

[58]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[59]  T. Richards,et al.  Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial , 2016, Intensive Care Medicine.

[60]  M. Bernabeu-Wittel,et al.  Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial , 2016, Transfusion.

[61]  Y. Cho,et al.  Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome. , 2016, Sleep medicine.

[62]  I. Robertson,et al.  Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. , 2016, The Lancet. Haematology.

[63]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[64]  G. Birgegard,et al.  A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial , 2016, Pharmacotherapy.

[65]  Christopher W Seymour,et al.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[66]  Rajvinder Singh,et al.  The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery , 2016, Annals of surgery.

[67]  S. Bonovas,et al.  Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease , 2016, Medicine.

[68]  Mark S Levenson,et al.  Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products. , 2015, JAMA.

[69]  Ben J. Marafino,et al.  Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[70]  P. Kalra,et al.  A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[71]  T. Richards,et al.  Effect of Intravenous Iron on Aerobic Capacity and Iron Metabolism in Elite Athletes. , 2015, Medicine and science in sports and exercise.

[72]  J. Kusek,et al.  A randomized trial of intravenous and oral iron in chronic kidney disease , 2015, Kidney international.

[73]  L. Thomsen,et al.  Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial) , 2015, Vox sanguinis.

[74]  F. Kronenberg,et al.  Iron Supplementation and Mortality in Incident Dialysis Patients: An Observational Study , 2014, PloS one.

[75]  Sunil V. Rao,et al.  A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. , 2014, Blood cells, molecules & diseases.

[76]  G. Birgegard,et al.  Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy , 2014, Medical Oncology.

[77]  T. Kuragano,et al.  Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients. , 2014, Kidney international.

[78]  K. Thompson,et al.  Four Weeks of IV Iron Supplementation Reduces Perceived Fatigue and Mood Disturbance in Distance Runners , 2014, PloS one.

[79]  E. Bisbe,et al.  Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. , 2014, British journal of anaesthesia.

[80]  E. Moore,et al.  A Multicenter, Randomized Clinical Trial of IV Iron Supplementation for Anemia of Traumatic Critical Illness* , 2014, Critical care medicine.

[81]  P. Ponikowski,et al.  Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency† , 2014, European heart journal.

[82]  I. Macdougall,et al.  FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[83]  Avantika Gupta,et al.  A Randomised Controlled Trial to Compare Intravenous Iron Sucrose and Oral Iron in Treatment of Iron Deficiency Anemia in Pregnancy , 2014, Indian Journal of Hematology and Blood Transfusion.

[84]  H. Sagili,et al.  Intravenous iron sucrose and oral iron for the treatment of iron deficiency anaemia in pregnancy. , 2014, Journal of clinical and diagnostic research : JCDR.

[85]  M. Palacio,et al.  Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial , 2014, BJOG : an international journal of obstetrics and gynaecology.

[86]  W. Winkelmayer,et al.  Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). , 2014, JAMA internal medicine.

[87]  J. Dahlerup,et al.  Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage – a placebo‐controlled study , 2014, Alimentary pharmacology & therapeutics.

[88]  Carol A. Keohane,et al.  Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. , 2013, JAMA internal medicine.

[89]  T. Manchana,et al.  Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. , 2013, Gynecologic oncology.

[90]  F. Baron,et al.  Darbepoetin‐alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial , 2013, American journal of hematology.

[91]  W. Reinisch,et al.  A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED) , 2013, The American Journal of Gastroenterology.

[92]  L. Rohde,et al.  IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. , 2013, International journal of cardiology.

[93]  T. Ganz Systemic iron homeostasis. , 2013, Physiological reviews.

[94]  David C. Ford,et al.  Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron , 2013, American journal of hematology.

[95]  K. Ho,et al.  Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials , 2013, BMJ.

[96]  A. Makhlough,et al.  Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial , 2013, Nephro-urology monthly.

[97]  W. Reinisch,et al.  State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.

[98]  T. Waldhör,et al.  Iron Deficiency Generates Secondary Thrombocytosis and Platelet Activation in IBD: the Randomized, Controlled ThromboVIT Trial , 2013, Inflammatory bowel diseases.

[99]  R. Harrington,et al.  A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia , 2013, Transfusion.

[100]  Eric P. Skaar,et al.  Iron in infection and immunity. , 2013, Cell host & microbe.

[101]  N. Hodyl,et al.  Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[102]  S. Jha,et al.  Intravenous Iron in Postpartum Anemia , 2013, The Journal of Obstetrics and Gynecology of India.

[103]  J. Cuenca,et al.  Very‐short‐term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients , 2013, Transfusion.

[104]  R. Testa,et al.  Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[105]  P. Marteau,et al.  Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[106]  P. Ghosh,et al.  Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: A randomized clinical trial , 2013, The journal of obstetrics and gynaecology research.

[107]  S. Leichtle,et al.  Construct domain analysis of patient health-related quality of life: physical and mental trajectory profiles following open versus endovascular repair of abdominal aortic aneurysm , 2012, Patient related outcome measures.

[108]  A. Jiménez-Sosa,et al.  The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. , 2012, Interactive cardiovascular and thoracic surgery.

[109]  A. Prentice,et al.  Hepcidin and the Iron-Infection Axis , 2012, Science.

[110]  L. Rai,et al.  Iron Sucrose Versus Oral Iron Therapy in Pregnancy Anemia , 2012, Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine.

[111]  D. Bregman,et al.  Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials , 2012, Anemia.

[112]  A. Sathe,et al.  Iron Deficiency Anemia in Pregnancy: Intravenous Versus Oral Route , 2012, The Journal of Obstetrics and Gynecology of India.

[113]  David W. Johnson,et al.  A Randomized Controlled Trial of Intravenous or Oral Iron for Posttransplant Anemia in Kidney Transplantation , 2012, Transplantation.

[114]  Y. Yoo,et al.  Effect of Single Recombinant Human Erythropoietin Injection on Transfusion Requirements in Preoperatively Anemic Patients Undergoing Valvular Heart Surgery , 2011, Anesthesiology.

[115]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[116]  C. Adler,et al.  Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. , 2011, Sleep medicine.

[117]  E. Battegay,et al.  Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. , 2011, Blood.

[118]  N. Malhotra,et al.  Intravenous Iron Therapy versus Oral Iron in Postpartum Patients in Rural Area , 2011 .

[119]  L. Adhikary,et al.  Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. , 2011, JNMA; journal of the Nepal Medical Association.

[120]  R. Shrivastava,et al.  Renal Association Clinical Practice Guideline on Anaemia of Chronic Kidney Disease , 2011, Nephron Clinical Practice.

[121]  P. C. Benítez,et al.  Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial , 2011, Transfusion.

[122]  C. Kim,et al.  Effects of intravenous iron combined with low‐dose recombinant human erythropoietin on transfusion requirements in iron‐deficient patients undergoing bilateral total knee replacement arthroplasty (CME) , 2011, Transfusion.

[123]  G. Birgegard,et al.  High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron , 2010, Vox sanguinis.

[124]  A. Mangione,et al.  A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[125]  T. Ciuleanu,et al.  Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy‐induced anemia , 2010, American journal of hematology.

[126]  J. Rasko,et al.  A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy , 2010, Journal of internal medicine.

[127]  G. Mantovani,et al.  Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study. , 2010, The oncologist.

[128]  P. Kerr,et al.  Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[129]  Penkae Dangsuwan,et al.  Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. , 2010, Gynecologic oncology.

[130]  G. Bailie,et al.  Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

[131]  P. Ponikowski,et al.  Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.

[132]  T. J. Edwards,et al.  Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery , 2009, The British journal of surgery.

[133]  A. Mangione,et al.  BLOOD MANAGEMENT: Large‐dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial , 2009, Transfusion.

[134]  R. Zimmermann,et al.  Iron prophylaxis in pregnancy: intravenous route versus oral route. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[135]  H. Chung,et al.  Safety and Usefulness of Intravenous Iron Sucrose in the Management of Preoperative Anemia in Patients with Menorrhagia: A Phase IV, Open-Label, Prospective, Randomized Study , 2009, Acta Haematologica.

[136]  B. Pereira,et al.  Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[137]  S. Lindgren,et al.  Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study , 2009, Scandinavian journal of gastroenterology.

[138]  D. Tarng,et al.  Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. , 2008, Journal of the American Society of Nephrology : JASN.

[139]  K. Salvesen,et al.  A 12‐week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia , 2008, Acta obstetricia et gynecologica Scandinavica.

[140]  A. Kausz,et al.  Ferumoxytol for treating iron deficiency anemia in CKD. , 2008, Journal of the American Society of Nephrology : JASN.

[141]  C. Breymann,et al.  Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[142]  T. Pintér,et al.  Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[143]  R. Labianca,et al.  Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[144]  G. D'Haens,et al.  A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial , 2008, The American Journal of Gastroenterology.

[145]  Shixiang Wang,et al.  Intravenous Iron Sucrose in Peritoneal Dialysis Patients with Renal Anemia , 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[146]  P. Ponikowski,et al.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2008, Journal of the American College of Cardiology.

[147]  Y. Yazdanpanah,et al.  Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis , 2007, Gut.

[148]  P. Duarte,et al.  Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. , 2007, Journal of the American College of Cardiology.

[149]  A. Mangione,et al.  Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Postpartum Anemia: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.

[150]  G. Birgegard,et al.  Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study , 2007, Leukemia.

[151]  Jae Hoon Kim,et al.  Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. , 2007, Gynecologic oncology.

[152]  Ajay K. Singh,et al.  Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. , 2007, Journal of the American Society of Nephrology : JASN.

[153]  N. Dahl,et al.  Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. , 2007, The oncologist.

[154]  A. Besarab,et al.  A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease , 2006, American Journal of Nephrology.

[155]  N. Bhandal,et al.  Intravenous versus oral iron therapy for postpartum anaemia , 2006, BJOG : an international journal of obstetrics and gynaecology.

[156]  J. Cangiano,et al.  Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[157]  A. Prentice,et al.  Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV. , 2006, Clinical science.

[158]  D. V. Van Wyck,et al.  A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. , 2005, Kidney international.

[159]  O. Kandemir,et al.  Intravenous Versus Oral Iron for Treatment of Anemia in Pregnancy: A Randomized Trial , 2005, Obstetrics and gynecology.

[160]  S. Schreiber,et al.  Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease—A Randomized, Controlled, Open-Label, Multicenter Study , 2005, The American Journal of Gastroenterology.

[161]  G. Bailie,et al.  Comparison of Intravenous Iron Sucrose to Oral Iron in the Treatment of Anemic Patients with Chronic Kidney Disease Not on Dialysis , 2005, Nephron Clinical Practice.

[162]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.

[163]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[164]  A. Kausz,et al.  Iron therapy in the pediatric hemodialysis population , 2004, Pediatric Nephrology.

[165]  A. Feigin,et al.  A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[166]  M. Auerbach,et al.  Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[167]  A. Yazigi,et al.  Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. , 2004, Journal of cardiothoracic and vascular anesthesia.

[168]  M. Müllner,et al.  High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. , 2003, Kidney international.

[169]  Hemant,et al.  Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin. , 2003, The Journal of the Association of Physicians of India.

[170]  A. Nissenson,et al.  Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. , 2002, Kidney international.

[171]  M. Laxenaire,et al.  Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. , 2002, American journal of obstetrics and gynecology.

[172]  L. Nogarin,et al.  Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo‐controlled trial , 2001, Transfusion.

[173]  A. van de Wiel,et al.  Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients , 2000, Critical care medicine.

[174]  G. Lauer,et al.  Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study , 1999, Transfusion.

[175]  M. Klimek,et al.  Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation , 1998, Transfusion.

[176]  P. Kuperan,et al.  A comparison between intravenous iron polymaltose complex (Ferrum Hausmann®) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy , 1998, European journal of haematology.

[177]  A. Al-Meshari,et al.  Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. , 1996, European journal of obstetrics, gynecology, and reproductive biology.

[178]  I. Macdougall,et al.  A randomized controlled study of iron supplementation in patients treated with erythropoietin. , 1996, Kidney international.

[179]  M. Meyer,et al.  A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. , 1996, The Journal of pediatrics.

[180]  B. Bistrian,et al.  Effect of iron-supplemented total parenteral nutrition in patients with iron deficiency anemia. , 1996, Nutrition.

[181]  S. Fishbane,et al.  The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients. , 1995, Clinical nephrology.

[182]  J. Friel,et al.  Intravenous iron administration to very-low-birth-weight newborns receiving total and partial parenteral nutrition. , 1995, JPEN. Journal of parenteral and enteral nutrition.

[183]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[184]  Shikha Madan,et al.  Oral Versus Intravenous Iron for Treatment of Iron Deficiency Anaemia in Pregnancy: A Randomized Controlled Trial , 2018 .

[185]  K. Kavitha,et al.  A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital , 2017 .

[186]  M. Azam,et al.  Comparison between Intravenous Iron and Oral Iron Therapy in Cases of Postpartum Anemia , 2017 .

[187]  Assem A. M. Elbiaa,et al.  Heme iron polypeptide (proferrin®-ES) versus iron saccharate complex (ferrosac) for treatment of iron deficiency anemia during pregnancy , 2017 .

[188]  J. Nath,et al.  Comparison of intravenous iron sucrose with oral iron in pregnant women with iron deficiency anaemia , 2016 .

[189]  L. Leibovici,et al.  The safety of intravenous iron preparations: systematic review and meta-analysis. , 2015, Mayo Clinic proceedings.

[190]  N. Pescosolido Therapeutics and clinical risk management , 2015 .

[191]  S. Samal,et al.  Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women , 2015, International journal of applied & basic medical research.

[192]  E. Martín-Montañez,et al.  Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. , 2014, Blood transfusion = Trasfusione del sangue.

[193]  V. Suri,et al.  Is it safe to use intravenous iron sucrose during pregnancy? A randomized controlled trial - , 2013 .

[194]  P. Novotny,et al.  Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[195]  S. Bélisle,et al.  Colloids use in the perioperative setting: a canadian review , 2006 .

[196]  J. Widness,et al.  Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. , 2001, Pediatrics.